Qiagen NV
(WBO:QGE2)
€
40.8
-0.54 (-1.31%)
Market Cap: 9.01 Bil
Enterprise Value: 9.48 Bil
PE Ratio: 137.61
PB Ratio: 2.86
GF Score: 87/100 
Qiagen NV at Barclays Global Healthcare Conference Transcript
Mar 14, 2019 / 02:15PM GMT
Release Date Price:
€36.37
(+0.54%)
Jack Meehan
Barclays Bank PLC, Research Division - Former VP & Senior Research Analyst
We're going to start quickly with 3 audience response questions, so please use the BlackBerrys in front of you.
First, what do you view as QIAGEN's organic growth profile over the next 3 years? Maybe a sneak peek for the Analyst Day. John can give us the answer later.
(Voting)
Jack Meehan
Barclays Bank PLC, Research Division - Former VP & Senior Research Analyst
Mid-single digits, some double digits, some low single.
Question two, do you expect organic growth to accelerate from current levels, and when?
(Voting)
Jack Meehan
Barclays Bank PLC, Research Division - Former VP & Senior Research Analyst
No, and yes, 2020.
And then finally, how would you like to see Peer and Roland and John deploy capital in 2019?
(Voting)
Jack Meehan
Barclays Bank PLC, Research Division - Former VP & Senior Research Analyst
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers